|
3JVF
Crystal structure of an Interleukin-17 receptor complex
Deposited 2009-09-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
32–317(286 aa)
Fragment:extracellular domain
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
CA CALCIUM ION × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 9.2;295 K;PEG6000, 0.1M CAPSO, calcium chloride, pH 9.2, VAPOR DIFFUSION, HANGING DROP, temperature 295K
|
Resolution 3.30 Å
R-free 0.256
|
|
4HSA
Structure of interleukin 17a in complex with il17ra receptor
Deposited 2012-10-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
32–317(286 aa)
|
Mutation:N175D, N234D
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 3.15 Å
R-free 0.232
|
|
4HSA
Structure of interleukin 17a in complex with il17ra receptor
Deposited 2012-10-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain F
32–317(286 aa)
|
Mutation:N175D, N234D
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 3.15 Å
R-free 0.232
|
|
4NUX
Structure of receptor A
Deposited 2013-12-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
376–591(216 aa)
Fragment:SEFIR domain (UNP residues 376-591)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;pH 6;293 K;0.1M MES, 5%PEG6000, pH 6.0, EVAPORATION, temperature 293K
|
Resolution 2.29 Å
R-free 0.242
|
|
5N9B
Crystal Structure of unliganded human IL-17RA
Deposited 2017-02-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
33–318(286 aa)
Fragment:Extracellular domain, UNP rsidues 33-318
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7;293 K;Tris-HCl, PEG 2000 MME, lithium sulfate
|
Resolution 1.90 Å
R-free 0.234
|
|
5NAN
Crystal Structure of human IL-17AF in complex with human IL-17RA
Deposited 2017-02-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
33–320(288 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.5;293 K;0.1M HEPES, 15% PEG MME 5,000, 0.05M Ammonium Acetate
|
Resolution 3.30 Å
R-free 0.243
|
|
5NAN
Crystal Structure of human IL-17AF in complex with human IL-17RA
Deposited 2017-02-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
33–320(288 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.5;293 K;0.1M HEPES, 15% PEG MME 5,000, 0.05M Ammonium Acetate
|
Resolution 3.30 Å
R-free 0.243
|
|
7UWL
Structure of the IL-25-IL-17RB-IL-17RA ternary complex
Deposited 2022-05-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain E
33–317(285 aa)
Chain F
33–317(285 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 14
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.70 Å
|
|
7UWM
Structure of the IL-17A-IL-17RA binary complex
Deposited 2022-05-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain C
33–304(272 aa)
Chain F
33–304(272 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.50 Å
|
|
7UWN
Structure of the IL-17A-IL-17RA-IL-17RC ternary complex
Deposited 2022-05-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 7
PDB declaration: heptameric
|
Chain C
33–317(285 aa)
Chain F
33–317(285 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 9
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.01 Å
|
|
7ZAN
Crystal Structure of human IL-17A in complex with IL-17RA and IL-17RC
Deposited 2022-03-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain C
33–320(288 aa)
|
Mutation:N49D, N206D, N265D
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 8
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1M MES, 10.0% PEG DME 500
|
Resolution 5.06 Å
R-free 0.353
|